Search results
The Paul-Ehrlich-Institut is an Agency of the German Federal Ministry of Health. Its research and control activities promote the quality, efficacy and safety of biological medicinal products.
- Clinical Trials
Each clinical trial for vaccines or biomedicines to be...
- Institute
Institute - Homepage - Paul-Ehrlich-Institut - PEI
- COVID-19 Vaccines
COVID-19 Vaccines - Homepage - Paul-Ehrlich-Institut - PEI
- History of The Paul-Ehrlich-Institut
Based on new legislation, the Paul-Ehrlich-Institut takes...
- Coronavirus and COVID-19
Coronavirus and COVID-19 - Homepage - Paul-Ehrlich-Institut...
- Official Duties
Official Duties - Homepage - Paul-Ehrlich-Institut - PEI
- Clinical Trials
The Paul Ehrlich Institute (German: Paul-Ehrlich-Institut – Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel, PEI) is a German federal agency, medical regulatory body and research institution for vaccines and biomedicines.
He was the founder and first director of what is now known as the Paul Ehrlich Institute, a German research institution and medical regulatory body that is the nation's federal institute for vaccines and biomedicines.
Jan 14, 2016 · The internationally recognised research conducted by the Paul-Ehrlich-Institut in the fields of virology, immunology, allerology, haematology, cell and genetic therapy improves the quality, safety and effectiveness of biomedicines.
At the end of 1896 an Institute for the control of therapeutic sera was established at Steglitz in Berlin and Ehrlich was appointed its Director. Here he did further important work on immunology, especially on haemolysins.
